Corinne Menn, DOMenopause and survivorship care

Frequently asked questions

Answers about telehealth visits, hormone therapy, nonhormone options, and menopause after cancer or with high risk.

Telehealth visits

Can I be seen from another state?

Telehealth care can only be given to patients who are physically located in a state where Dr. Menn is licensed at the time of the visit. Licensing details are listed on the About page.

What can a telehealth visit do, and what can't it do?

A video visit covers your history, symptoms, records, options and a plan, including prescriptions where appropriate. It can't include a physical or pelvic exam, Pap test, ultrasound, procedure or surgery. Your local clinicians stay important for those.

Does Dr. Menn provide pregnancy care or surgery?

No. This practice focuses on menopause, survivorship and high-risk consultation and education. It does not offer prenatal or obstetric care, in-person exams or surgery.

Do you take insurance? What does a visit cost?

Please ask about fees and insurance by email at [email protected] before booking.

What should I have ready for my first visit?

Your last period and cycle changes, a short symptom diary, a list of medicines and supplements, any cancer treatment summary, genetic results, recent mammogram, bone density and blood tests, and your questions.

Is the contact form secure for medical details?

Please don't send detailed medical information through the website form. Once you're a patient, you'll get a secure way to share records.

Menopause and hormones

How do I know if I'm in perimenopause?

Usually from your age, symptoms and changes in your cycle. Because hormone levels swing from day to day, a single blood test rarely settles it, though tests can help rule out other causes.

Is hormone therapy safe?

For healthy women under 60 or within 10 years of menopause, the benefits usually outweigh the risks when hormone therapy is used for bothersome hot flashes or to prevent bone loss. Risks are higher when it's started later, and some health histories, including breast cancer, generally rule out systemic therapy. It's an individual decision.[1]

How long can I stay on hormone therapy?

There's no single cut-off. Current guidance supports continuing for documented reasons, such as persistent hot flashes, with a review of benefits and risks at least once a year.[1]

What are the nonhormone options for hot flashes?

Options with good evidence include CBT, clinical hypnosis, certain antidepressants (SSRIs and SNRIs), gabapentin, oxybutynin and fezolinetant. Most herbal supplements haven't been shown to work.[2]

Are compounded “bioidentical” hormones better?

The Menopause Society does not recommend routine use of compounded hormones. They aren't FDA-approved, and their dose and purity can vary. FDA-approved hormone products, including ones identical to the body's own estradiol and progesterone, are available.[1]

After cancer and high risk

Can I use vaginal estrogen after breast cancer?

Sometimes. ACOG advises trying nonhormone treatments first. If they don't help enough, low-dose vaginal estrogen may be considered after a discussion of risks and benefits. For women on aromatase inhibitors, the decision should be made together with the oncologist.[3]

I carry a BRCA variant and plan to have my ovaries removed. What happens to menopause?

Removing the ovaries causes menopause right away if you haven't reached it. ACOG advises offering hormone therapy afterward to women who haven't had breast cancer. Planning ahead makes the transition easier.[4]

Will you replace my oncologist or gynecologist?

No. Consults add menopause expertise to your existing team. Cancer treatment decisions stay with your oncologist, and exams and procedures with your local clinicians.

Sources for this page

  1. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. View source (opens in a new tab)
  2. The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause. 2023;30(6):573-590. View source (opens in a new tab)
  3. American College of Obstetricians and Gynecologists. Treatment of urogenital symptoms in individuals with a history of estrogen-dependent breast cancer. Clinical Consensus No. 2. Obstet Gynecol. 2021;138(6):950-960. View source (opens in a new tab)
  4. American College of Obstetricians and Gynecologists. Hereditary breast and ovarian cancer syndrome. Practice Bulletin No. 182. Obstet Gynecol. 2017;130(3):e110-e126. View source (opens in a new tab)

Start with a conversation

Request a telehealth consult. You'll get a reply with next steps, intake forms and booking options.

Request a consult